Related Experiment Video
Updated: Feb 13, 2026

Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
[Pharmacological treatment of asthma during pregnancy]
S A van Nederveen-Bendien1, S R J van Oord-Bosselaar, A H Feitsma
1HagaZiekenhuis, Den Haag.
Insights
Asthma in pregnancy increases risks for preterm birth and low birth weight. However, using asthma medications like inhaled corticosteroids (ICS) and bronchodilators during pregnancy is generally safe and recommended for better outcomes.
Area of Science:
- Obstetrics and Gynecology
- Pulmonology
- Pharmacology
Background:
- Asthma during pregnancy is linked to adverse outcomes like preterm delivery, low birth weight, and pre-eclampsia.
- Concerns regarding the teratogenic effects of asthma medications contribute to undertreatment among healthcare professionals and pregnant individuals.
- Existing data suggests a low risk of teratogenic effects from commonly used inhaled asthma medications.
Purpose of the Study:
- To evaluate the risks associated with asthma during pregnancy.
- To assess the safety and efficacy of asthma pharmacotherapy in pregnant individuals.
- To provide recommendations for the management of asthma in pregnant women.
Main Methods:
- Review of existing literature on asthma in pregnancy.
- Analysis of teratogenic risk data for inhaled corticosteroids (ICS), short-acting beta-agonists (SABA), and long-acting beta-agonists (LABA).
- Comparison of outcomes between well-controlled asthma and uncontrolled asthma during pregnancy.
Main Results:
- Asthma in pregnancy is associated with increased risks of preterm delivery, low birth weight, and pre-eclampsia.
- Inhaled asthma medications (ICS, SABA, LABA) have a small risk of teratogenic effects and have been used safely by many patients.
- Well-controlled asthma during pregnancy via pharmacological therapy is safer than managing asthma symptoms and exacerbations.
Conclusions:
- Managing asthma effectively with medication during pregnancy is crucial for reducing maternal and fetal complications.
- The benefits of controlled asthma outweigh the minimal risks associated with prescribed inhaled asthma medications.
- Preconception counseling and ongoing management are recommended for pregnant women with asthma.
Abstract:
- Asthma during pregnancy is associated with an increased risk of preterm delivery, low birth weight and pre-eclampsia.- This condition may be undertreated due to insufficient knowledge and, in particular, concerns about teratogenic effects of asthma medication among treating healthcare professionals and pregnant women.- The risk of teratogenic effects of inhaled medications (ICS, SABA and LABA) is small. These agents have been used by large groups of patients for many years.- Well-controlled asthma with pharmacological therapy during pregnancy is safer and leads to fewer complications then accepting asthma symptoms and exacerbations.- Preconception care for a woman with asthma who is treated with medication is recommended.
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Nursing Management
First, in...

